HC Wainwright Brokers Decrease Earnings Estimates for CDTX
Cidara Therapeutics, Inc. (NASDAQ:CDTX – Free Report) – Investment analysts at HC Wainwright dropped their Q1 2025 earnings per share estimates for Cidara Therapeutics in a report issued on Monday, March 10th. HC Wainwright analyst E. Arce now anticipates that the biotechnology company will post earnings of ($5.45) per share for the quarter, down from […]
